195 related articles for article (PubMed ID: 22219068)
21. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity.
Bickels J; Manusama ER; Gutman M; Eggermont AM; Kollender Y; Abu-Abid S; Van Geel AN; Lev-Shlush D; Klausner JM; Meller I
Eur J Surg Oncol; 1999 Oct; 25(5):509-14. PubMed ID: 10527599
[TBL] [Abstract][Full Text] [Related]
22. Oncological outcome after hyperthermic isolated limb perfusion for primarily unresectable versus locally recurrent soft tissue sarcoma of extremities.
Vassos N; Brunner M; Perrakis A; Göhl J; Grützmann R; Hohenberger W; Croner RS
Surg Oncol; 2020 Dec; 35():162-168. PubMed ID: 32882523
[TBL] [Abstract][Full Text] [Related]
23. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: three time periods at risk for amputation.
van Ginkel RJ; Thijssens KM; Pras E; van der Graaf WT; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2007 Apr; 14(4):1499-506. PubMed ID: 17253101
[TBL] [Abstract][Full Text] [Related]
24. Lower limb function and quality of life after ILP for soft-tissue sarcoma.
Podleska LE; Kaya N; Farzaliyev F; Pöttgen C; Bauer S; Taeger G
World J Surg Oncol; 2017 Apr; 15(1):84. PubMed ID: 28403880
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities.
Farzaliyev F; Touma A; Taeger G; Steinau HU; Hardes J; Streitbürger A; Podleska LE
World J Surg Oncol; 2020 Dec; 18(1):332. PubMed ID: 33349267
[TBL] [Abstract][Full Text] [Related]
26. Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma.
Andreou D; Werner M; Pink D; Traub F; Schuler MK; Gosheger G; Jobke B; Reichardt P; Tunn PU
Int J Hyperthermia; 2016; 32(2):159-64. PubMed ID: 26670477
[TBL] [Abstract][Full Text] [Related]
27. Tumor vascularization and histopathologic regression of soft tissue sarcomas treated with isolated limb perfusion with TNF-α and melphalan.
Grabellus F; Kraft C; Sheu-Grabellus SY; Bauer S; Podleska LE; Lauenstein TC; Pöttgen C; Konik MJ; Schmid KW; Taeger G
J Surg Oncol; 2011 Apr; 103(5):371-9. PubMed ID: 21400518
[TBL] [Abstract][Full Text] [Related]
28. Limb desmoid tumors: a possible role for isolated limb perfusion with tumor necrosis factor-alpha and melphalan.
Lev-Chelouche D; Abu-Abeid S; Nakache R; Issakov J; Kollander Y; Merimsky O; Meller I; Klausner JM; Gutman M
Surgery; 1999 Nov; 126(5):963-7. PubMed ID: 10568198
[TBL] [Abstract][Full Text] [Related]
29. High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation.
Gutman M; Inbar M; Lev-Shlush D; Abu-Abid S; Mozes M; Chaitchik S; Meller I; Klausner JM
Cancer; 1997 Mar; 79(6):1129-37. PubMed ID: 9070490
[TBL] [Abstract][Full Text] [Related]
30. The oncological outcomes of isolated limb perfusion and neo-adjuvant radiotherapy in soft tissue sarcoma patients - A nationwide multicenter study.
van Praag VM; Fiocco M; Bleckman RF; van Houdt WJ; Haas RLM; Verhoef C; Grunhagen DJ; van Ginkel RJ; Bonenkamp JJ; van de Sande MAJ
Eur J Surg Oncol; 2023 Feb; 49(2):339-344. PubMed ID: 36085118
[TBL] [Abstract][Full Text] [Related]
31. Feasibility and efficacy of external beam radiotherapy after hyperthermic isolated limb perfusion with TNF-alpha and melphalan for limb-saving treatment in locally advanced extremity soft-tissue sarcoma.
Olieman AF; Pras E; van Ginkel RJ; Molenaar WM; Schraffordt Koops H; Hoekstra HJ
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):807-14. PubMed ID: 9531364
[TBL] [Abstract][Full Text] [Related]
32. Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor α for In-Transit Melanoma and Soft Tissue Sarcoma.
Smith HG; Cartwright J; Wilkinson MJ; Strauss DC; Thomas JM; Hayes AJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S356-61. PubMed ID: 26350373
[TBL] [Abstract][Full Text] [Related]
33. Hyperthermic isolated limb perfusion with tumour necrosis factor and melphalan as treatment of locally advanced or recurrent soft tissue sarcomas of the extremities.
Schraffordt Koops H; Eggermont AM; Liènard D; Kroon BB; Hoekstra HJ; van Geel AN; Nieweg OE; Lejeune FJ
Radiother Oncol; 1998 Jul; 48(1):1-4. PubMed ID: 9756165
[TBL] [Abstract][Full Text] [Related]
34. Isolated limb perfusion is an effective treatment modality for locally advanced Kaposi sarcoma of the extremities.
Boere T; Huis In 't Veld EA; Deroose JP; van Ginhoven TM; Wouters MWJM; Grünhagen DJ; Verhoef C; van Houdt WJ
Eur J Surg Oncol; 2020 Jul; 46(7):1315-1319. PubMed ID: 32359920
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of ¹⁸F-FDG PET uptake in patients with locally advanced, extremity soft tissue sarcomas undergoing neoadjuvant isolated limb perfusion with TNF-α and melphalan.
Andreou D; Boldt H; Pink D; Jobke B; Werner M; Schuler M; Reichardt P; Tunn PU
Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1076-83. PubMed ID: 24519553
[TBL] [Abstract][Full Text] [Related]
36. Hyperthermic isolated limb perfusion, preoperative radiotherapy, and surgery (PRS) a new limb saving treatment strategy for locally advanced sarcomas.
Stevenson MG; Seinen JM; Pras E; Brouwers AH; van Ginkel RJ; van Leeuwen BL; Suurmeijer AJH; Been LB; Hoekstra HJ
J Surg Oncol; 2018 Jun; 117(7):1447-1454. PubMed ID: 29484661
[TBL] [Abstract][Full Text] [Related]
37. Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review.
Bhangu A; Broom L; Nepogodiev D; Gourevitch D; Desai A
Eur J Surg Oncol; 2013 Apr; 39(4):311-9. PubMed ID: 23351681
[TBL] [Abstract][Full Text] [Related]
38. Hyperthermic isolated limb perfusion in locally advanced soft tissue sarcoma and progressive desmoid-type fibromatosis with TNF 1 mg and melphalan (T1-M HILP) is safe and efficient.
Bonvalot S; Rimareix F; Causeret S; Le Péchoux C; Boulet B; Terrier P; Le Cesne A; Muret J
Ann Surg Oncol; 2009 Dec; 16(12):3350-7. PubMed ID: 19830495
[TBL] [Abstract][Full Text] [Related]
39. Isolated limb perfusion with tumor necrosis factor and melphalan prevents amputation in patients with multiple sarcomas in arm or leg.
Grünhagen DJ; Brunstein F; Graveland WJ; van Geel AN; de Wilt JH; Eggermont AM
Ann Surg Oncol; 2005 Jun; 12(6):473-9. PubMed ID: 15864484
[TBL] [Abstract][Full Text] [Related]
40. Impact of hyperthermic isolated limb perfusion on tumour oxygenation in soft tissue sarcoma.
Jakob J; von Rege I; Weiss C; Hohenberger P
Int J Hyperthermia; 2012; 28(7):591-6. PubMed ID: 22946472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]